Cindy Leissinger

6.4k total citations
103 papers, 2.6k citations indexed

About

Cindy Leissinger is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Cindy Leissinger has authored 103 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Hematology, 29 papers in Genetics and 9 papers in Surgery. Recurrent topics in Cindy Leissinger's work include Hemophilia Treatment and Research (76 papers), Platelet Disorders and Treatments (42 papers) and Blood Coagulation and Thrombosis Mechanisms (22 papers). Cindy Leissinger is often cited by papers focused on Hemophilia Treatment and Research (76 papers), Platelet Disorders and Treatments (42 papers) and Blood Coagulation and Thrombosis Mechanisms (22 papers). Cindy Leissinger collaborates with scholars based in United States, Italy and Canada. Cindy Leissinger's co-authors include W. Keith Hoots, Bruce M. Ewenstein, Rebecca Kruse‐Jarres, Philip M. Blatt, Joan Cox Gill, Craig M. Kessler, Peter W. Collins, Christine L. Kempton, Andreas Tiede and Paul Knoebl and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Cindy Leissinger

99 papers receiving 2.5k citations

Peers

Cindy Leissinger
Pratima Chowdary United Kingdom
Rendrik F. Franco Brazil
P.M. Mannucci Italy
Sabrina Gavasso Italy
Annarita Tagliaferri Italy
Agnès Veyradier France
Yesim Dargaud France
Shruti Chaturvedi United States
J Wilde United Kingdom
Takeshi Matsumoto Japan
Pratima Chowdary United Kingdom
Cindy Leissinger
Citations per year, relative to Cindy Leissinger Cindy Leissinger (= 1×) peers Pratima Chowdary

Countries citing papers authored by Cindy Leissinger

Since Specialization
Citations

This map shows the geographic impact of Cindy Leissinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Leissinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Leissinger more than expected).

Fields of papers citing papers by Cindy Leissinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Leissinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Leissinger. The network helps show where Cindy Leissinger may publish in the future.

Co-authorship network of co-authors of Cindy Leissinger

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Leissinger. A scholar is included among the top collaborators of Cindy Leissinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Leissinger. Cindy Leissinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vir, Pooja, Batsukh Dorjbal, Dennis P. McDaniel, et al.. (2024). Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk. Journal of Thrombosis and Haemostasis. 22(12). 3415–3430.
2.
Escobar, Miguel A., Cindy Leissinger, & Guy Young. (2022). Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life. Journal of the Advanced Practitioner in Oncology. 13(4). 7–19. 2 indexed citations
3.
Doshi, Bhavya S., Giancarlo Castaman, Radosław Kaczmarek, et al.. (2021). B cell–activating factor modulates the factor VIII immune response in hemophilia A. Journal of Clinical Investigation. 131(8). 17 indexed citations
4.
Buckner, Tyler W., Andrew D. Leavitt, Margaret V. Ragni, et al.. (2016). Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery. Thrombosis and Haemostasis. 116(7). 42–49. 28 indexed citations
5.
Miller, Connie H., Brian Boylan, Amanda B. Payne, et al.. (2015). Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening. American Journal of Hematology. 90(10). 871–876. 7 indexed citations
6.
Leissinger, Cindy. (2015). Advances in the clinical management of inhibitors in hemophilia A and B. Seminars in Hematology. 53(1). 20–27. 16 indexed citations
7.
Leissinger, Cindy, Cassandra D. Josephson, Barbara A. Konkle, et al.. (2014). Rituximab for treatment of inhibitors in haemophilia A. Thrombosis and Haemostasis. 112(9). 445–458. 35 indexed citations
8.
9.
Jo, Hyunji, A. Gringeri, Cindy Leissinger, et al.. (2011). PSY47 Evaluating the Cross-over Effect on Health-related Quality of Life in a Randomized Cross-over Study of Hemophilia-A Patients. Value in Health. 14(7). A418–A419. 1 indexed citations
10.
Barnett, Brian, et al.. (2008). Immune tolerance induction for the eradication of inhibitors in patients with hemophilia A. Expert Opinion on Biological Therapy. 8(12). 1885–1896. 3 indexed citations
11.
Kruse‐Jarres, Rebecca, et al.. (2008). Emergency Department Care for Patients with Hemophilia and Von Willebrand Disease. Journal of Emergency Medicine. 39(2). 158–165. 34 indexed citations
12.
Barnett, Brian, Rebecca Kruse‐Jarres, & Cindy Leissinger. (2008). Current management of acquired factor VIII inhibitors. Current Opinion in Hematology. 15(5). 451–455. 18 indexed citations
13.
14.
Berntorp, Erik, Jan Astermark, V. Blanchette, et al.. (2006). Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference. Haemophilia. 12(s6). 1–7. 82 indexed citations
15.
Tenenbaum, Scott A., Cindy A. Morris, Steve S. Alexander, et al.. (2005). Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera. Virology Journal. 2(1). 65–65. 9 indexed citations
16.
Ewenstein, Bruce M., J. Heinrich Joist, Amy D. Shapiro, et al.. (2002). Pharmacokinetic analysis of plasma‐derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B. Transfusion. 42(2). 190–197. 85 indexed citations
17.
18.
Hewitt, Robert L., Donald L. Akers, Cindy Leissinger, Javed Gill, & Richard H. Aster. (1998). Concurrence of anaphylaxis and acute heparin-induced thrombocytopenia in a patient with heparin-induced antibodies. Journal of Vascular Surgery. 28(3). 561–565. 17 indexed citations
19.
Leissinger, Cindy & W. J. Stuckey. (1992). Unbound immunoglobulins are a major source of error in the quantitation of platelet surface‐bound immunoglobulin levels. Transfusion. 32(2). 157–161. 3 indexed citations
20.
Leissinger, Cindy & W. Abe Andes. (1992). Role of splenectomy in the management of hemophilic patients with human immunodeficiency virus‐associated immunopathic thrombocytopenic purpura. American Journal of Hematology. 40(3). 207–209. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pratima Chowdary Breakdown of academic impact, for papers by Rendrik F. Franco Breakdown of academic impact, for papers by P.M. Mannucci Breakdown of academic impact, for papers by Sabrina Gavasso Breakdown of academic impact, for papers by Annarita Tagliaferri Breakdown of academic impact, for papers by Agnès Veyradier Breakdown of academic impact, for papers by Yesim Dargaud Breakdown of academic impact, for papers by Shruti Chaturvedi Breakdown of academic impact, for papers by J Wilde Breakdown of academic impact, for papers by Takeshi Matsumoto
Rankless by CCL
2026